Our Priorities Innovating for the Future
Abbott was founded 125 years ago to pursue science and innovation in health care, and our passion for researching and developing sustainable solutions to health care challenges continues to drive us. Each of our core businesses – in medical devices, diagnostics, medicines and nutritional products – continues to invest in new research, new technologies and new approaches.
Our ongoing investment in research and development – $4.1 billion in 2011 – allows us to foster new insights and solutions to health care challenges and then translate them into life-enhancing products with strong commercial viability. Our commitment to innovation extends beyond the laboratory to our close collaboration with our customers and our close attention to local health care needs. We believe innovation is just as important in improving how health care is delivered as it is in researching and developing new health care products.
Each of Abbott’s businesses is working to advance people’s health and well-being globally, with innovative health care products that we develop to address vital needs. Chronic diseases like diabetes and heart disease, long common in developed nations, now are endemic in developing countries as well. In response, Abbott is leveraging its expertise and resources to fight familiar diseases in new environments. Around the world, we are partnering with numerous academics, nonprofits, governments and private companies to combat many of the world’s most pressing health challenges, lending our expertise in disease diagnosis and treatment.
Note: All data in the Global Citizenship section reflects activities prior to the separation of Abbott and AbbVie on January 1, 2013.